1: Pandey S, Venugopal A, Kant R, Coleman R, Mukherjee J. ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors. Nucl Med Biol. 2014 May-Jun;41(5):426-31. doi: 10.1016/j.nucmedbio.2014.01.011. Epub 2014 Jan 31. PMID: 24602412; PMCID: PMC4004701.
2: de Paulis T. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain. Curr Pharm Des. 2003;9(8):673-96. doi: 10.2174/1381612033391135. PMID: 12570798.
3: Huang YR, Pai CW, Cheng KH, Kuo WI, Chen MW, Chang KW. Dopamine D(2)/D(3) receptor binding of [(123)I]epidepride in risperidone-treatment chronic MK-801-induced rat schizophrenia model using nanoSPECT/CT neuroimaging. Nucl Med Biol. 2014 Sep;41(8):681-7. doi: 10.1016/j.nucmedbio.2014.04.133. Epub 2014 May 9. PMID: 24927927.
4: Huang YR, Shih JM, Chang KW, Huang C, Wu YL, Chen CC. [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model. Nucl Med Biol. 2012 Aug;39(6):826-32. doi: 10.1016/j.nucmedbio.2012.01.005. Epub 2012 Mar 29. PMID: 22464847.
5: Almeida P, Ribeiro MJ, Bottlaender M, Loc'h C, Langer O, Strul D, Hugonnard P, Grangeat P, Mazière B, Bendriem B. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography. Eur J Nucl Med. 1999 Dec;26(12):1580-8. doi: 10.1007/s002590050498. PMID: 10638410.
6: de Herder WW, Reijs AE, de Swart J, Kaandorp Y, Lamberts SW, Krenning EP, Kwekkeboom DJ. Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas. Eur J Nucl Med. 1999 Jan;26(1):46-50. doi: 10.1007/s002590050358. PMID: 9933661.
7: Neve KA, Henningsen RA, Kinzie JM, De Paulis T, Schmidt DE, Kessler RM, Janowsky A. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand. J Pharmacol Exp Ther. 1990 Mar;252(3):1108-16. PMID: 2138666.
8: Tibbo P, Silverstone PH, McEwan AJ, Scott J, Joshua A, Golberg K. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls. J Psychiatry Neurosci. 1997 Jan;22(1):39-45. PMID: 9002391; PMCID: PMC1188815.
9: Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT. J Nucl Med. 1996 Dec;37(12):1931-7. PMID: 8970508.
10: Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse. 1996 Jun;23(2):115-23. doi: 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C. PMID: 8723716.
11: Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors. Nucl Med Biol. 1999 Jul;26(5):509-18. doi: 10.1016/s0969-8051(99)00005-0. PMID: 10473189.
12: Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al- Tikriti M, Manning RG, Gillespie D. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Life Sci. 1991;49(8):617-28. doi: 10.1016/0024-3205(91)90261-9. PMID: 1830917.
13: Pinborg LH, Videbaek C, Ziebell M, Mackeprang T, Friberg L, Rasmussen H, Knudsen GM, Glenthoj BY. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage. 2007 Feb 15;34(4):1450-3. doi: 10.1016/j.neuroimage.2006.11.003. Epub 2006 Dec 18. PMID: 17175177.
14: Leung K. (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F] fluoropropyl)-2-methoxybenzamide. 2006 Aug 3 [updated 2008 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641474.
15: Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. J Nucl Med. 1997 Nov;38(11):1711-7. PMID: 9374338.
16: Leung K. (+/-)-2-(N-Cyclohexylethyl-N-[11C]propyl)a mino-5-hydroxytetralin. 2006 Aug 16 [updated 2008 Feb 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641389.
17: Leung K. (R,S)-2-(N-Propyl-N-5'-[18F] fluoropentyl)amino-5-hydroxytetralin. 2006 Aug 27 [updated 2008 Feb 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641295.
18: Baldwin RM, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Seibyl JP, Sybirska EH, Malison RT, Laruelle M, Charney DS, Hoffer PB, et al. Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates. Nucl Med Biol. 1994 Oct;21(7):969-76. doi: 10.1016/0969-8051(94)90087-6. PMID: 9234352.
19: Leung K. (R)-2-[11C]Methoxy-N-n-propylnorapomorphine. 2006 Apr 11 [updated 2012 Feb 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641879.
20: Leung K. (R)-(-)-2-Chloro-N-[1-11C-propyl]n- propylnorapomorphine. 2010 Oct 24 [updated 2010 Dec 11]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21204317.